TB drug resistance in the U.S.
Published Date:OCTOBER 2015
Corporate Authors:National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
Series:CDC fact sheet
Description:Causes of TB drug resistance -- Multidrug-resistant TB (MDR TB) -- Extensively drug-resistant TB (XDR TB) -- The financial toll of drug resistance --TB drug shortages -- Preventing drug-resistant TB.
Tuberculosis (TB) is a serious disease caused by bacteria that are spread from person to person through the air. TB usually
affects the lungs, but it can also affect other parts of the body, such as the brain, the kidneys, or the spine. In most cases,
TB is treatable and curable; however, TB can be deadly without proper treatment.
TB bacteria can become resistant to the drugs used for treatment. When this occurs, treatment is often still possible, but
it is complex, long, challenging, and expensive. Treatment can disrupt lives and have serious, potentially life-threatening
Rates of drug-resistant TB remain relatively low in the United States, though nearly half a million cases of multidrugresistant
TB are estimated to occur globally each year.1 These cases underscore the need for ongoing vigilance and action,
especially given the ease with which TB can be spread through international travel and migration.
The Centers for Disease Control and Prevention (CDC) works with state and local health departments and other health
care providers to prevent the spread of TB, track drug-resistant cases, assist with diagnosis as needed, and help ensure
that patients with drug-resistant TB receive effective treatment and care.
Supporting Files:No Additional Files
You May Also Like: